Efficacy and Safety of Ocedurenone: Subgroup Analysis of the BLOCK-CKD Study

BACKGROUND: Ocedurenone (KBP-5074), a nonsteroidal mineralocorticoid receptor antagonist, is documented to lower blood pressure in patients with stage 3b/4 chronic kidney disease (CKD) with uncontrolled or resistant hypertension (BLOCK-CKD study). However, the efficacy and safety of Ocedurenone in s...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakris, George L, Yang, Y Fred, McCabe, James M, Liu, Jin Rong, Tan, Xiaojuan J, Benn, Vincent J, Pitt, Bertram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570658/
https://www.ncbi.nlm.nih.gov/pubmed/37471468
http://dx.doi.org/10.1093/ajh/hpad066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570658/
https://www.ncbi.nlm.nih.gov/pubmed/37471468
http://dx.doi.org/10.1093/ajh/hpad066

Ejemplares similares